RecruitingNCT00411983

A Long-term Follow-up of the HIV-NAT Cohort

A Long-term Follow-up Study for HIV-infected Individuals Who Have Participated in HIV-NAT Study Protocols

Sponsor

The HIV Netherlands Australia Thailand Research Collaboration

Enrollment

10,000 participants

Start Date

Nov 1, 2002

Study Type

OBSERVATIONAL

Conditions

HIV Infections

Summary

With HIV/AIDS increasingly considered a chronic disease, 24-, or 48-week data from antiretroviral studies are no longer sufficient. Only with long-term follow-up and outcome data will shed some much-needed light on the answers of questions that have stumped us for several years. Data from a large observational cohort of patients treated with combination antiretroviral therapy will provide further insights into the long-term safety and durability of various antiretroviral therapeutic approached, the efficacy of HIV viral load and CD4 cell counts as predictors of disease progression and mortality, and the importance of adherence.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This long-term study follows HIV-positive patients in Thailand who are receiving antiretroviral therapy, tracking their health outcomes and how well the treatment works over many years. **You may be eligible if...** - You are HIV-positive and enrolled in, or previously participated in, the HIV-NAT cohort study in Thailand - You are currently receiving antiretroviral therapy - You are willing to attend regular clinic visits and allow access to your medical records **You may NOT be eligible if...** - You are not HIV-positive - You are unable or unwilling to attend follow-up visits - You are not connected to a participating HIV-NAT study site Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.